-
Mashup Score: 28
A randomized, controlled trial (RCT) shows that even at a higher dose and longer treatment duration, the antimalarial drug ivermectin didn’t shorten the time to a sustained recovery from COVID-19. In the double-blind trial, published yesterday in JAMA, a team led by Duke University researchers evaluated time to sustained recovery among 1,206 COVID-19 patients at 93 US sites from Feb 16 to Jul…
Source: CIDRAPCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 1Higher-Dose Ivermectin vs Placebo and Time to Sustained Recovery in Outpatients With COVID-19 - 1 year(s) ago
This platform randomized clinical trial examines the effectiveness ivermectin at a targeted dose of 600 μg/kg daily compared with placebo for the treatment of early mild to moderate COVID-19.
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3Higher-Dose Ivermectin vs Placebo and Time to Sustained Recovery in Outpatients With COVID-19 - 1 year(s) ago
This platform randomized clinical trial examines the effectiveness ivermectin at a targeted dose of 600 μg/kg daily compared with placebo for the treatment of early mild to moderate COVID-19.
Source: jamanetwork.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 7Colorado Doc Put on Probation for Ivermectin Prescriptions - 1 year(s) ago
Scott Rollins, MD, and the state medical board reached an agreement on ‘unprofessional conduct’
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 14Dispensing of Ivermectin From Veterans Administration Pharmacies During the COVID-19 Pandemic - 1 year(s) ago
This cohort study compares changes in ivermectin dispensing during the COVID-19 pandemic between the Veterans Administration (VA) and retail pharmacy settings and examines the association of the VA national formulary restriction with ivermectin dispensing.
Source: jamanetwork.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 1Medical Board Takes Action Against Misinformation Doc - 1 year(s) ago
Pathologist Ryan Cole, MD, is facing discipline for negligence, spreading false statements
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Emergency Medicine, Latest HeadlinesTweet
-
Mashup Score: 0A mixed methods study exploring requests for unproven COVID therapies such as ivermectin and healthcare distrust in the rural South - 1 year(s) ago
The COVID-19 pandemic has led to contentious discourse regarding unproven COVID-19 therapies (UCTs),(e.g. ivermectin). Despite recommendations against…
Source: www.sciencedirect.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 3MedinCell - Technology | Value innovation - 1 year(s) ago
MedinCell is a pharmaceutical company at premarketing stage that develops innovative long-acting injectable medicines in many therapeutic areas.
Source: MEDINCELLCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 3
Background Despite the development and application of vaccines against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) around the world, the scientific community is still trying to find some therapies to avoid or ameliorate the fatal evolution of the Coronavirus disease 2019 (COVID-19). Since the publication of the potential use of ivermectin as a treatment against the disease, a…
Source: BioMed CentralCategories: Healthcare Professionals, Latest HeadlinesTweet
Higher ivermectin dose, longer duration still futile for #COVID19, trial finds The median time to sustained recovery was 11 days in both the #ivermectin and placebo group https://t.co/ip3TRgQWNg https://t.co/eTuuQ74stV